MétaCan
Menu
← Back to cohort

Fecal Calprotectin: A Biomarker and Predictor of Disease Activity During Pregnancy in Women with IBD

2015· article· en· W2978388747 on OpenAlexaff
Vivian Huang, Jasmin Bal, Lindsy Ambrosio, Rae Foshaug, Karen I. Kroeker, Levinus A. Dieleman, Brendan P. Halloran, Richard N. Fedorak

Bibliographic record

VenueThe American Journal of Gastroenterology · 2015
Typearticle
Languageen
FieldMedicine
TopicPregnancy and Medication Impact
Canadian institutionsUniversity of Alberta
Fundersnot available
KeywordsMedicineCalprotectinInflammatory bowel diseasePregnancyBiomarkerUlcerative colitisInternal medicineDiseaseCrohn's diseaseGastroenterologyObstetricsImmunology

Abstract

fetched live from OpenAlex

Introduction: Active inflammatory bowel disease (IBD) during pregnancy is associated with adverse maternal and fetal outcomes, and therefore requires early optimization of therapy. Women with inflammatory bowel disease (IBD) often have gastrointestinal symptoms during pregnancy, but it is often difficult to differentiate between pregnancy symptoms and active IBD. Fecal calprotectin (FCP) is a noninvasive biomarker of intestinal inflammation used to guide the management of IBD. Whether FCP can be used as a biomarker to identify active disease in pregnant women with IBD who have symptoms is not well understood. The objectives of this study were to determine if FCP is elevated during pregnancy in women with IBD who 1) have active disease or 2) who flare within 3 months of the FCP measurment. Methods: Women with IBD (18 to 45 yrs) were followed pre-conception (PC) and at each trimester of pregnancy (T[n]) in the Preconception and Pregnancy in IBD clinic. Women completed the modified Harvey Bradshaw Index (mHBI) for Crohn's disease and the partial Mayo (pMayo) for ulcerative colitis. Women with mHBI > 5 or pMayo > 2 were identified as having clinically active disease. FCP was determined from the first morning stool sample from each visit using the Quantum Blue High Range Reader. We compared the FCP of the women who 1) had active disease vs inactive disease at each study visit, and 2) who flared within 3 months vs who do not flare within 3 months of the FCP measurement. Results: Of the 60 patients enrolled in the clinic, 9 women with Crohn's disease, and 13 women with ulcerative colitis provided stool samples over 27 visits. FCP was elevated in women with active disease compared to women with inactive disease at each clinic visit (Figure 1). FCP was also elevated in women who flared within 3 months (Figure 2). These findings were mainly seen among women with UC.Figure 1Figure 2Conclusion: Fecal calprotectin is elevated before and during pregnancy in women with active IBD, and in women who will flare within 3 months of FCP measurement. FCP has a potential to be used as a noninvasive biomarker of disease activity during pregnancy in women with IBD - in order to confirm disease activity or to identify those at risk of flaring, so that clincians can optimize the management of IBD preconception and during pregnancy, and thus improve maternal and fetal outcomes.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.001
metaresearch head score (Gemma)0.003
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.002
Threshold uncertainty score0.005

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0010.003
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0000.000
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0010.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.016
GPT teacher head0.267
Teacher spread0.251 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations0
Published2015
Admission routes1
Has abstractyes

Explore more

Same venueThe American Journal of Gastroenterology→Same topicPregnancy and Medication Impact→French-language works237,207→